Aortic Stenosis Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies
DelveInsight’s Aortic Stenosis market report offers comprehensive coverage of the current treatment practices, pipeline therapies, and market share of the individual drug, current and forecasted Aortic Stenosis market size from 2018 to 2030 in the 7MM.
Some of the Key Highlights from the Aortic Stenosis Market Report
-
Aortic stenosis is the most common type of valvular heart disease in Europe and the second most common in the United States.
-
According to a study by Pujari et al. (2021), the calcific aortic stenosis prevalence is approximately 1% to 2% in patients aged 65 or more, 12% in patients aged 65 or more, and about 3.4% of patients aged greater than 75 have severe aortic stenosis.
-
Leading players such as MyoKardia, Cytokinetics, and others are working diligently towards developing novel therapies for Aortic Stenosis treatment.
-
Key Aortic Stenosis therapies in the pipeline include Mavacamten, CK-274, and others.
-
Mavacamten (MyoKardia) has been designated as a breakthrough therapy and an orphan drug by the US FDA for the potential treatment of symptomatic, obstructive HCM.
For further information related to disease, request for the sample @ Aortic Stenosis Market Outlook
Aortic Stenosis Overview
Aortic Stenosis is the obstruction of blood flow across the aortic valve. Mortality from the onset of symptoms is approximately 25% at one year and 50% at two years in symptomatic patients with medically treated moderate-to-severe aortic stenosis. Symptoms of aortic stenosis usually appear gradually after an asymptomatic latent period of 10-20 years.
Aortic Stenosis Epidemiology Segmentation
The Aortic Stenosis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
-
Aortic Stenosis Prevalent Cases
-
Aortic Stenosis Gender-Specific Cases
-
Aortic Stenosis Age-Specific Cases
Aortic Stenosis Treatment Landscape
There are no approved medications to reverse or slow the progression of Aortic Stenosis. Still, medications such as statins, lipid-lowering therapies, and ACE inhibitor therapies are used to manage the disease symptomatically. The current major options for Aortic Stenosis treatment include Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), and Percutaneous Balloon Valvuloplasty
Aortic Stenosis Market Outlook
Extensive research and development activities by pharmaceutical companies such as MyoKardia, Cytokinetics, and others and the anticipated launch of approved therapies such as Mavacamten, CK-274, and others will drive Aortic Stenosis market growth during the forecast period, i.e., 2021–2030.
Get a detailed analysis of the market @ Aortic Stenosis Market Analysis
Aortic Stenosis Pipeline Therapie and Key Companies
-
Mavacamten: MyoKardia
-
CK-274: Cytokinetics
Table of Contents
1. |
Report Introduction |
2. |
Aortic Stenosis (AS) Market Overview at a Glance |
3. |
Disease Background and Overview: Aortic Stenosis (AS) |
4. |
Aortic Stenosis Epidemiology and Patient Population |
5. |
Aortic Stenosis Treatments & Medical Practices |
6. |
Aortic Stenosis Marketed Therapy |
7. |
Aortic Stenosis Emerging Therapies |
8. |
Key Cross Competition |
9. |
Aortic Stenosis (AS) Market Size |
10. |
Aortic Stenosis (AS): Country-Wise Market Analysis |
11. |
Aortic Stenosis United States Market Size |
12. |
Aortic Stenosis Germany Market Size |
13. |
Aortic Stenosis France Market Size |
14. |
Aortic Stenosis Italy Market Size |
15. |
Aortic Stenosis Spain Market Size |
16. |
Aortic Stenosis United Kingdom Market Size |
17. |
Aortic Stenosis Japan Market Size |
18. |
Report Methodology |
19. |
DelveInsight Capabilities |
20. |
Disclaimer |
21. |
About DelveInsight |
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Abdominal Aortic Aneurysm Market
DelveInsight’s “Abdominal Aortic Aneurysm – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the 7MM.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/